What is he best known for?
The fields of study he is best known for:
His primary scientific interests are in Cell biology, microRNA, Gene expression, Genetics and Genetic screen.
His Cell biology study combines topics from a wide range of disciplines, such as RNA, Cell cycle, RNA interference, Gene and Chromosome passenger complex.
His microRNA research is multidisciplinary, incorporating elements of Cancer, Cancer research, Downregulation and upregulation, Tensin and RNA-binding protein.
The RNA-binding protein study combines topics in areas such as Three prime untranslated region and Untranslated region.
Reuven Agami combines subjects such as Small interfering RNA, CDC25A, Internal medicine, Matrigel and Gene silencing with his study of Gene expression.
His Genetic screen research is multidisciplinary, relying on both Carcinogenesis, Nuclease protection assay and Endogeny.
His most cited work include:
- A System for Stable Expression of Short Interfering RNAs in Mammalian Cells (4483 citations)
- Stable suppression of tumorigenicity by virus-mediated RNA interference. (1114 citations)
- A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors (1072 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Cell biology, Gene, Genetics, microRNA and Cancer research.
His Cell biology research is multidisciplinary, incorporating perspectives in Gene expression, Protein biosynthesis, Regulation of gene expression, Transcription and Genetic screen.
His Gene study integrates concerns from other disciplines, such as Molecular biology and Function.
His Genetics study deals with Computational biology intersecting with Epigenomics.
His microRNA course of study focuses on Cervical cancer and Demethylating agent.
His Cancer research research integrates issues from Cancer cell, Cancer, Breast cancer and Cell growth.
He most often published in these fields:
- Cell biology (55.81%)
- Gene (33.72%)
- Genetics (36.63%)
What were the highlights of his more recent work (between 2017-2021)?
- Cell biology (55.81%)
- Enhancer (26.16%)
- Regulation of gene expression (27.91%)
In recent papers he was focusing on the following fields of study:
Reuven Agami spends much of his time researching Cell biology, Enhancer, Regulation of gene expression, Transcription and Transcription factor.
His research integrates issues of Carcinogenesis, Messenger RNA, Gene, Protein biosynthesis and Ribosome in his study of Cell biology.
His work in Carcinogenesis addresses subjects such as Oncogene, which are connected to disciplines such as Gene expression.
His Enhancer research incorporates themes from Cancer and Estrogen receptor alpha.
The study incorporates disciplines such as Cancer research and DNA repair in addition to Cancer.
His Regulation of gene expression study also includes fields such as
- Estrogen receptor which connect with Genetic screen,
- CRISPR, which have a strong connection to Genome, Regulator and AP-1 transcription factor.
Between 2017 and 2021, his most popular works were:
- SCAF4 and SCAF8, mRNA Anti-Terminator Proteins (29 citations)
- Long non-coding RNAs in metastasis. (24 citations)
- FcαRI co-stimulation converts human intestinal CD103+ dendritic cells into pro-inflammatory cells through glycolytic reprogramming. (22 citations)
In his most recent research, the most cited papers focused on:
His main research concerns Cell biology, Gene, Senescence, Gene expression and Regulation of gene expression.
His study in Cell biology is interdisciplinary in nature, drawing from both MRNA Sequencing, Proinflammatory cytokine and Ribosome.
His Gene research is multidisciplinary, incorporating elements of Serine and Protein biosynthesis.
His Senescence study combines topics from a wide range of disciplines, such as Carcinogenesis, Oncogene, Ectopic expression, RNA interference and Gene silencing.
His biological study spans a wide range of topics, including Terminator, Gene knockdown, Metastasis, Long non-coding RNA and Computational biology.
His Regulation of gene expression study combines topics in areas such as CRISPR, Genome, Enhancer, Regulator and AP-1 transcription factor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
